Report ID: GIR2303020003 | Category: Pharma & Healthcare | Pages: 101 | Format: PDF | Published Date: March 13,2023
1 Market Overview 1.1 Product Overview and Scope of Severe Asthma Treatment 1.2 Market Estimation Caveats and Base Year 1.3 Market Analysis by Type 1.3.1 Overview: Global Severe Asthma Treatment Consumption Value by Type: 2018 Versus 2022 Versus 2029 1.3.2 Oral 1.3.3 lnhaled 1.3.4 lntravenous 1.3.5 Subcutaneous 1.4 Market Analysis by Application 1.4.1 Overview: Global Severe Asthma Treatment Consumption Value by Application: 2018 Versus 2022 Versus 2029 1.4.2 Children 1.4.3 Adults 1.4.4 Teenagers 1.5 Global Severe Asthma Treatment Market Size & Forecast 1.5.1 Global Severe Asthma Treatment Consumption Value (2018 & 2022 & 2029) 1.5.2 Global Severe Asthma Treatment Sales Quantity (2018-2029) 1.5.3 Global Severe Asthma Treatment Average Price (2018-2029) 2 Manufacturers Profiles 2.1 Teva Pharmaceutical 2.1.1 Teva Pharmaceutical Details 2.1.2 Teva Pharmaceutical Major Business 2.1.3 Teva Pharmaceutical Severe Asthma Treatment Product and Services 2.1.4 Teva Pharmaceutical Severe Asthma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.1.5 Teva Pharmaceutical Recent Developments/Updates 2.2 AstraZeneca 2.2.1 AstraZeneca Details 2.2.2 AstraZeneca Major Business 2.2.3 AstraZeneca Severe Asthma Treatment Product and Services 2.2.4 AstraZeneca Severe Asthma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.2.5 AstraZeneca Recent Developments/Updates 2.3 GlaxoSmithKline 2.3.1 GlaxoSmithKline Details 2.3.2 GlaxoSmithKline Major Business 2.3.3 GlaxoSmithKline Severe Asthma Treatment Product and Services 2.3.4 GlaxoSmithKline Severe Asthma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.3.5 GlaxoSmithKline Recent Developments/Updates 2.4 Novartis 2.4.1 Novartis Details 2.4.2 Novartis Major Business 2.4.3 Novartis Severe Asthma Treatment Product and Services 2.4.4 Novartis Severe Asthma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.4.5 Novartis Recent Developments/Updates 2.5 Sanofi 2.5.1 Sanofi Details 2.5.2 Sanofi Major Business 2.5.3 Sanofi Severe Asthma Treatment Product and Services 2.5.4 Sanofi Severe Asthma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.5.5 Sanofi Recent Developments/Updates 2.6 Regeneron Pharmaceutical 2.6.1 Regeneron Pharmaceutical Details 2.6.2 Regeneron Pharmaceutical Major Business 2.6.3 Regeneron Pharmaceutical Severe Asthma Treatment Product and Services 2.6.4 Regeneron Pharmaceutical Severe Asthma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.6.5 Regeneron Pharmaceutical Recent Developments/Updates 2.7 4D Pharma plc 2.7.1 4D Pharma plc Details 2.7.2 4D Pharma plc Major Business 2.7.3 4D Pharma plc Severe Asthma Treatment Product and Services 2.7.4 4D Pharma plc Severe Asthma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.7.5 4D Pharma plc Recent Developments/Updates 2.8 AB Pharma 2.8.1 AB Pharma Details 2.8.2 AB Pharma Major Business 2.8.3 AB Pharma Severe Asthma Treatment Product and Services 2.8.4 AB Pharma Severe Asthma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.8.5 AB Pharma Recent Developments/Updates 2.9 Morphosys 2.9.1 Morphosys Details 2.9.2 Morphosys Major Business 2.9.3 Morphosys Severe Asthma Treatment Product and Services 2.9.4 Morphosys Severe Asthma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.9.5 Morphosys Recent Developments/Updates 2.10 Roche 2.10.1 Roche Details 2.10.2 Roche Major Business 2.10.3 Roche Severe Asthma Treatment Product and Services 2.10.4 Roche Severe Asthma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.10.5 Roche Recent Developments/Updates 2.11 Avalo Therapeutics 2.11.1 Avalo Therapeutics Details 2.11.2 Avalo Therapeutics Major Business 2.11.3 Avalo Therapeutics Severe Asthma Treatment Product and Services 2.11.4 Avalo Therapeutics Severe Asthma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.11.5 Avalo Therapeutics Recent Developments/Updates 2.12 Suzhou Connect Biopharmaceuticals 2.12.1 Suzhou Connect Biopharmaceuticals Details 2.12.2 Suzhou Connect Biopharmaceuticals Major Business 2.12.3 Suzhou Connect Biopharmaceuticals Severe Asthma Treatment Product and Services 2.12.4 Suzhou Connect Biopharmaceuticals Severe Asthma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.12.5 Suzhou Connect Biopharmaceuticals Recent Developments/Updates 2.13 Pieris Pharma 2.13.1 Pieris Pharma Details 2.13.2 Pieris Pharma Major Business 2.13.3 Pieris Pharma Severe Asthma Treatment Product and Services 2.13.4 Pieris Pharma Severe Asthma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.13.5 Pieris Pharma Recent Developments/Updates 2.14 Biosion 2.14.1 Biosion Details 2.14.2 Biosion Major Business 2.14.3 Biosion Severe Asthma Treatment Product and Services 2.14.4 Biosion Severe Asthma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.14.5 Biosion Recent Developments/Updates 3 Competitive Environment: Severe Asthma Treatment by Manufacturer 3.1 Global Severe Asthma Treatment Sales Quantity by Manufacturer (2018-2023) 3.2 Global Severe Asthma Treatment Revenue by Manufacturer (2018-2023) 3.3 Global Severe Asthma Treatment Average Price by Manufacturer (2018-2023) 3.4 Market Share Analysis (2022) 3.4.1 Producer Shipments of Severe Asthma Treatment by Manufacturer Revenue ($MM) and Market Share (%): 2022 3.4.2 Top 3 Severe Asthma Treatment Manufacturer Market Share in 2022 3.4.2 Top 6 Severe Asthma Treatment Manufacturer Market Share in 2022 3.5 Severe Asthma Treatment Market: Overall Company Footprint Analysis 3.5.1 Severe Asthma Treatment Market: Region Footprint 3.5.2 Severe Asthma Treatment Market: Company Product Type Footprint 3.5.3 Severe Asthma Treatment Market: Company Product Application Footprint 3.6 New Market Entrants and Barriers to Market Entry 3.7 Mergers, Acquisition, Agreements, and Collaborations 4 Consumption Analysis by Region 4.1 Global Severe Asthma Treatment Market Size by Region 4.1.1 Global Severe Asthma Treatment Sales Quantity by Region (2018-2029) 4.1.2 Global Severe Asthma Treatment Consumption Value by Region (2018-2029) 4.1.3 Global Severe Asthma Treatment Average Price by Region (2018-2029) 4.2 North America Severe Asthma Treatment Consumption Value (2018-2029) 4.3 Europe Severe Asthma Treatment Consumption Value (2018-2029) 4.4 Asia-Pacific Severe Asthma Treatment Consumption Value (2018-2029) 4.5 South America Severe Asthma Treatment Consumption Value (2018-2029) 4.6 Middle East and Africa Severe Asthma Treatment Consumption Value (2018-2029) 5 Market Segment by Type 5.1 Global Severe Asthma Treatment Sales Quantity by Type (2018-2029) 5.2 Global Severe Asthma Treatment Consumption Value by Type (2018-2029) 5.3 Global Severe Asthma Treatment Average Price by Type (2018-2029) 6 Market Segment by Application 6.1 Global Severe Asthma Treatment Sales Quantity by Application (2018-2029) 6.2 Global Severe Asthma Treatment Consumption Value by Application (2018-2029) 6.3 Global Severe Asthma Treatment Average Price by Application (2018-2029) 7 North America 7.1 North America Severe Asthma Treatment Sales Quantity by Type (2018-2029) 7.2 North America Severe Asthma Treatment Sales Quantity by Application (2018-2029) 7.3 North America Severe Asthma Treatment Market Size by Country 7.3.1 North America Severe Asthma Treatment Sales Quantity by Country (2018-2029) 7.3.2 North America Severe Asthma Treatment Consumption Value by Country (2018-2029) 7.3.3 United States Market Size and Forecast (2018-2029) 7.3.4 Canada Market Size and Forecast (2018-2029) 7.3.5 Mexico Market Size and Forecast (2018-2029) 8 Europe 8.1 Europe Severe Asthma Treatment Sales Quantity by Type (2018-2029) 8.2 Europe Severe Asthma Treatment Sales Quantity by Application (2018-2029) 8.3 Europe Severe Asthma Treatment Market Size by Country 8.3.1 Europe Severe Asthma Treatment Sales Quantity by Country (2018-2029) 8.3.2 Europe Severe Asthma Treatment Consumption Value by Country (2018-2029) 8.3.3 Germany Market Size and Forecast (2018-2029) 8.3.4 France Market Size and Forecast (2018-2029) 8.3.5 United Kingdom Market Size and Forecast (2018-2029) 8.3.6 Russia Market Size and Forecast (2018-2029) 8.3.7 Italy Market Size and Forecast (2018-2029) 9 Asia-Pacific 9.1 Asia-Pacific Severe Asthma Treatment Sales Quantity by Type (2018-2029) 9.2 Asia-Pacific Severe Asthma Treatment Sales Quantity by Application (2018-2029) 9.3 Asia-Pacific Severe Asthma Treatment Market Size by Region 9.3.1 Asia-Pacific Severe Asthma Treatment Sales Quantity by Region (2018-2029) 9.3.2 Asia-Pacific Severe Asthma Treatment Consumption Value by Region (2018-2029) 9.3.3 China Market Size and Forecast (2018-2029) 9.3.4 Japan Market Size and Forecast (2018-2029) 9.3.5 Korea Market Size and Forecast (2018-2029) 9.3.6 India Market Size and Forecast (2018-2029) 9.3.7 Southeast Asia Market Size and Forecast (2018-2029) 9.3.8 Australia Market Size and Forecast (2018-2029) 10 South America 10.1 South America Severe Asthma Treatment Sales Quantity by Type (2018-2029) 10.2 South America Severe Asthma Treatment Sales Quantity by Application (2018-2029) 10.3 South America Severe Asthma Treatment Market Size by Country 10.3.1 South America Severe Asthma Treatment Sales Quantity by Country (2018-2029) 10.3.2 South America Severe Asthma Treatment Consumption Value by Country (2018-2029) 10.3.3 Brazil Market Size and Forecast (2018-2029) 10.3.4 Argentina Market Size and Forecast (2018-2029) 11 Middle East & Africa 11.1 Middle East & Africa Severe Asthma Treatment Sales Quantity by Type (2018-2029) 11.2 Middle East & Africa Severe Asthma Treatment Sales Quantity by Application (2018-2029) 11.3 Middle East & Africa Severe Asthma Treatment Market Size by Country 11.3.1 Middle East & Africa Severe Asthma Treatment Sales Quantity by Country (2018-2029) 11.3.2 Middle East & Africa Severe Asthma Treatment Consumption Value by Country (2018-2029) 11.3.3 Turkey Market Size and Forecast (2018-2029) 11.3.4 Egypt Market Size and Forecast (2018-2029) 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029) 11.3.6 South Africa Market Size and Forecast (2018-2029) 12 Market Dynamics 12.1 Severe Asthma Treatment Market Drivers 12.2 Severe Asthma Treatment Market Restraints 12.3 Severe Asthma Treatment Trends Analysis 12.4 Porters Five Forces Analysis 12.4.1 Threat of New Entrants 12.4.2 Bargaining Power of Suppliers 12.4.3 Bargaining Power of Buyers 12.4.4 Threat of Substitutes 12.4.5 Competitive Rivalry 12.5 Influence of COVID-19 and Russia-Ukraine War 12.5.1 Influence of COVID-19 12.5.2 Influence of Russia-Ukraine War 13 Raw Material and Industry Chain 13.1 Raw Material of Severe Asthma Treatment and Key Manufacturers 13.2 Manufacturing Costs Percentage of Severe Asthma Treatment 13.3 Severe Asthma Treatment Production Process 13.4 Severe Asthma Treatment Industrial Chain 14 Shipments by Distribution Channel 14.1 Sales Channel 14.1.1 Direct to End-User 14.1.2 Distributors 14.2 Severe Asthma Treatment Typical Distributors 14.3 Severe Asthma Treatment Typical Customers 15 Research Findings and Conclusion 16 Appendix 16.1 Methodology 16.2 Research Process and Data Source 16.3 Disclaimer
It contains all the geographic trends, and market analysis for global market